Nearly 200 attendees and 20 expert speakers gathered in Philadelphia for a two-day deep dive into the executive and clinical aspects of delivering the country’s most sophisticated memory care services. Read More »
Nearly 200 attendees and 20 expert speakers are gathering in Philadelphia for a two-day deep dive into the executive and clinical aspects of delivering the country’s most sophisticated memory care services. Read More »
Memory Cafes, a concept born in the Netherlands, are growing in popularity across the country as a way for families and those with cognitive impairment to communicate and socialize on their own terms. Read More »
Early diagnosis of Alzheimer’s disease is difficult. Atypical forms of the disease can be even more challenging to identify, requiring different assessment tools and interventions. Read More »
Loneliness and isolation affect almost half of adults over age 65, yet few clinical programs address them head on as medical factors that affect treatment outcomes. Read More »
An Alzheimer’s organization is planning a seven-day Caribbean cruise where people with dementia and their loved ones can relax, learn about the disease and meet others in the same boat. Read More »
A new study has found that teaching staff to identify unmet needs in residents with dementia led to fewer “behaviors” and ultimately reduced use of antipsychotic medications. Read More »
The organization teamed up with Alzheimer’s Disease International to index dementia treatment best practices and readiness to combat the disease across G7 countries. Read More »
Although the terms are sometimes confused among lay people, the two conditions often develop independently from each other. Having both can cause the fastest decline of all, a new study shows. Read More »
The prevalence of antipsychotics in SNFs has dropped consistently since the CMS mandate to reduce unnecessary usage went into effect in 2012. Read More »
Do you know a dementia care CNA who goes above and beyond the call of duty? Nominations are now being accepted for the National Council of Certified Dementia Practitioners CNA of the Year award. Read More »
The U.S. Food and Drug Administration has approved 23andMe to market personal genetic tests for Alzheimer’s, Parkinson’s and celiac disease, among others for less than the cost of a new smartphone. Read More »
Neurocrine Biosciences, Inc. has received government approval for the first drug to treat tardive dyskinesia, a neurological disorder that causes involuntary movements. Read More »
Kelly Papa took her idea for a dementia network and built it into a summit and an all-year dialogue that stretches across the state of Connecticut. Read More »
The new bill proposes funding for training as more organizations urge the need for better support for hospice and palliative care in professional settings and at home. Read More »
